Health care utilization among adenosine-sensitive supraventricular tachycardia patients presenting to the emergency department

[1] Orejarena LA(1998)Paroxysmal supraventricular tachycardia in the general population J Am Coll Cardiol 31 150-157

[2] Vidaillet H(2007)U.S. emergency department visits for supraventricular tachycardia, 1993–2003 Acad Emerg Med Off J Soc Acad Emerg Med 14 578-581

[3] DeStefano F(2006)Clinical practice. Supraventricular tachycardia N Engl J Med 354 1039-1051

[4] Nordstrom DL(1992)Adenosine and the treatment of supraventricular tachycardia Am J Med 92 655-664

[5] Vierkant RA(2001)Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia J Am Coll Cardiol 37 548-553

[6] Smith PN(2001)Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo Am Heart J 142 93-98

[7] Hayes JJ(1982)Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial Ann Intern Med 96 409-412

[8] Murman DH(1984)Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil Am J Cardiol 54 1138-1139

[9] McDonald AJ(1994)Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group Am J Cardiol 74 578-584

[10] Pelletier AJ(1991)Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy Ann Intern Med 114 539-544

[1] Orejarena LA(1998)Paroxysmal supraventricular tachycardia in the general population J Am Coll Cardiol 31 150-157

[2] Vidaillet H(2007)U.S. emergency department visits for supraventricular tachycardia, 1993–2003 Acad Emerg Med Off J Soc Acad Emerg Med 14 578-581

[3] DeStefano F(2006)Clinical practice. Supraventricular tachycardia N Engl J Med 354 1039-1051

[4] Nordstrom DL(1992)Adenosine and the treatment of supraventricular tachycardia Am J Med 92 655-664

[5] Vierkant RA(2001)Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia J Am Coll Cardiol 37 548-553

[6] Smith PN(2001)Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo Am Heart J 142 93-98

[7] Hayes JJ(1982)Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial Ann Intern Med 96 409-412

[8] Murman DH(1984)Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil Am J Cardiol 54 1138-1139

[9] McDonald AJ(1994)Flecainide acetate for paroxysmal supraventricular tachyarrhythmias. The Flecainide Supraventricular Tachycardia Study Group Am J Cardiol 74 578-584

[10] Pelletier AJ(1991)Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy Ann Intern Med 114 539-544